FGF-23 has been found to supplant phosphate in multivariable analyses of predictors of survival time in cats with CKD (Geddes et al., 2015), and has been reported to upregulate of components of the TGF-β1 signalling pathway in mouse models (Dai et al., 2012). This evidence concerns the gene TGFB1 and chronic kidney disease.